Inhibition of effects of flow on potassium permeability in single perfused frog mesenteric capillaries

J Physiol. 1999 Apr 1;516 ( Pt 1)(Pt 1):201-7. doi: 10.1111/j.1469-7793.1999.201aa.x.

Abstract

1. We have investigated the effects of various potential inhibitors on flow-dependent K+ permeability (PK) of single perfused mesenteric microvessels in pithed frogs. 2. Neither superfusion with a nitric oxide synthase inhibitor, NG-monomethyl-L-arginine (10 or 100 micromol l-1), nor the addition of indomethacin (30 micromol l-1) to both perfusate and superfusate reduced the positive correlation between PK and flow velocity (U). 3. In the presence of agents known to raise intracellular levels of adenosine 3',5'-cyclic monophosphate (noradrenaline, 8-bromo-cAMP and a combination of forskolin and rolipram) the slope of the relation between PK and U was no longer significant, so that PK was no longer flow dependent. 4. These results confirm that the flow dependence of PK is a biological process and not an artefact of measurement and suggest a role for intracellular cAMP rather than nitric oxide or prostacyclin in the flow-dependent modulation of PK in frog mesenteric microvessels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Capillaries / drug effects
  • Capillaries / metabolism
  • Cyclic AMP / physiology
  • Cyclooxygenase Inhibitors / pharmacology
  • Decerebrate State
  • Epoprostenol / physiology
  • In Vitro Techniques
  • Indomethacin / pharmacology
  • Kinetics
  • Male
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / metabolism*
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase Type III
  • Potassium Channels / drug effects
  • Potassium Channels / metabolism*
  • Rana pipiens
  • Rana temporaria
  • Splanchnic Circulation / drug effects
  • omega-N-Methylarginine / pharmacology

Substances

  • Cyclooxygenase Inhibitors
  • Potassium Channels
  • omega-N-Methylarginine
  • Epoprostenol
  • Cyclic AMP
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type III
  • Indomethacin